Table 3.

Baseline comparison of intervention group (n=73) with control group (n=69)

Characteristic	Intervention group (n=73)	Control group (n=69)
Mean age (SD) (years)	66.6 (11.5)	65.9 (10.8)
Male	n=33 (45.2%)	n=44 (63.8%)
Histology of lesion
BCC	n=55 (75.3%)	n=52 (75.4%)
SCC	n=7 (9.6%)	n=8 (11.6%)
IEC	n=10 (13.7%)	n=9 (13.0%)
Dysplastic naevus	n=1 (1.4%)	n=0
Body site of lesion
Nose	n=55 (75.3%)	n=45 (65.2%)
Ear	n=18 (24.7%)	n=24 (34.8%)
Smoker	n=4 (5.5%)	n=6 (8.7%)
Diabetes mellitus	n=8 (11.0%)	n=8 (11.6%)
Anticoagulant medication	n=19 (26.0%)	n=17 (24.6%)
Immunosuppressive medication	n=1 (1.4%)	n=1 (1.4%)
Median time to surgery (IQR) (min)	50 (45–55)	50 (45–55)
Modified MMS*	n=10 (13.7%)	n=12 (17.4%)
Surgical repair technique
Flap repair	n=68 (94.5%)	n=58 (88.4%)
Skin graft	n=3 (4.1%)	n=6 (8.7%)
Wedge excision	n=1 (1.4%)	n = 2 (2.9%)
Median defect size (IQR); range (mm)	13 (11.5–16); 9–25	14 (12–16.5); 9–30

*Delayed surgical closure awaiting complete histological margin analysis.

MMS, Mohs micrographic surgery.